Department of Pediatrics, National Hospital Organization, Okayama Medical Center, 1711-1 Tamasu, Kita-ku, Okayama, 701-1192, Japan.
Indian J Pediatr. 2018 Apr;85(4):261-265. doi: 10.1007/s12098-017-2509-8. Epub 2017 Nov 11.
To assess the effects of growth hormone (GH) on lipid profiles in children and whether the effect is pharmacological.
The authors determined serum levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and low-density lipoprotein cholesterol (LDL-C) every year during 3-y GH treatment in 48 GH deficient (GHD) short children and 22 children with short stature born small for gestational age (SGA).
The abnormally high levels of TC, non-HDL-C, and LDL-C showed a high frequency in GHD short children compared with epidemiological studies in Japan. The high prevalence of high level of TC was also shown in SGA short children. Three-year GH treatment decreased serum TC, non-HDL-C, and LDL-C levels in both patient groups.
GH treatment is clearly a pharmacological therapy in SGA short children and so may also be in GHD short children at the Japanese standard therapeutic dose. Taken together, GH improves lipid profiles, and its effect has the possibility of medical properties.
评估生长激素 (GH) 对儿童血脂谱的影响,以及这种影响是否具有药理学作用。
作者在 3 年内对 48 名生长激素缺乏症 (GHD) 矮小儿童和 22 名因宫内发育迟缓而身材矮小的儿童进行了 GH 治疗,每年检测一次总胆固醇 (TC)、高密度脂蛋白胆固醇 (HDL-C)、非高密度脂蛋白胆固醇 (non-HDL-C) 和低密度脂蛋白胆固醇 (LDL-C) 的血清水平。
与日本的流行病学研究相比,GHD 矮小儿童的 TC、non-HDL-C 和 LDL-C 水平异常升高。SGA 矮小儿童的 TC 水平升高也很常见。3 年的 GH 治疗降低了两组患儿的血清 TC、non-HDL-C 和 LDL-C 水平。
GH 治疗在 SGA 矮小儿童中显然是一种药理学治疗,因此在日本标准治疗剂量下,对 GHD 矮小儿童也可能如此。综上所述,GH 可改善血脂谱,其作用具有一定的医疗特性。